These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 22226772

  • 1. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
    Li F, Li QH, Wang JY, Zhan CY, Xie C, Lu WY.
    J Control Release; 2012 Apr 30; 159(2):261-70. PubMed ID: 22226772
    [Abstract] [Full Text] [Related]

  • 2. The improving effects on hepatic fibrosis of interferon-γ liposomes targeted to hepatic stellate cells.
    Li Q, Yan Z, Li F, Lu W, Wang J, Guo C.
    Nanotechnology; 2012 Jul 05; 23(26):265101. PubMed ID: 22700686
    [Abstract] [Full Text] [Related]

  • 3. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
    Bansal R, Prakash J, de Ruijter M, Beljaars L, Poelstra K.
    Mol Pharm; 2011 Oct 03; 8(5):1899-909. PubMed ID: 21800888
    [Abstract] [Full Text] [Related]

  • 4. Long-Circulating Liposomal Delivery System Targeting at PDGFR-β Enhances the Therapeutic Effect of IFN-α on Hepatic Fibrosis.
    Li Q, Yu Q, Ju J, You T, Yan Z, Nan X, Zhong J, Zhou JE.
    Curr Pharm Des; 2017 Oct 03; 23(20):3034-3046. PubMed ID: 27928957
    [Abstract] [Full Text] [Related]

  • 5. Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats.
    Chen SW, Chen YX, Zhang XR, Qian H, Chen WZ, Xie WF.
    Gene Ther; 2008 Nov 03; 15(21):1424-35. PubMed ID: 18509379
    [Abstract] [Full Text] [Related]

  • 6. Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo.
    Bansal R, Prakash J, De Ruiter M, Poelstra K.
    J Control Release; 2014 Apr 10; 179():18-24. PubMed ID: 24491909
    [Abstract] [Full Text] [Related]

  • 7. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis.
    Baroni GS, D'Ambrosio L, Curto P, Casini A, Mancini R, Jezequel AM, Benedetti A.
    Hepatology; 1996 May 10; 23(5):1189-99. PubMed ID: 8621153
    [Abstract] [Full Text] [Related]

  • 8. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
    Adrian JE, Poelstra K, Scherphof GL, Meijer DK, van Loenen-Weemaes AM, Reker-Smit C, Morselt HW, Zwiers P, Kamps JA.
    J Pharmacol Exp Ther; 2007 May 10; 321(2):536-43. PubMed ID: 17314198
    [Abstract] [Full Text] [Related]

  • 9. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
    Li J, Liu P, Zhang R, Cao L, Qian H, Liao J, Xu W, Wu M, Yin Z.
    J Ethnopharmacol; 2011 Sep 01; 137(1):714-23. PubMed ID: 21726622
    [Abstract] [Full Text] [Related]

  • 10. Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats.
    Du SL, Pan H, Lu WY, Wang J, Wu J, Wang JY.
    J Pharmacol Exp Ther; 2007 Aug 01; 322(2):560-8. PubMed ID: 17510318
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
    Paik YH, Kim JK, Lee JI, Kang SH, Kim DY, An SH, Lee SJ, Lee DK, Han KH, Chon CY, Lee SI, Lee KS, Brenner DA.
    Gut; 2009 Nov 01; 58(11):1517-27. PubMed ID: 19201774
    [Abstract] [Full Text] [Related]

  • 12. Sterically stable liposomes improve the therapeutic effect of hepatic stimulator substance on fulminant hepatic failure in rats.
    Li F, Sun JY, Liu M, Lu WY, Wang JY, Shi JY.
    Biochem Pharmacol; 2011 Sep 01; 82(5):556-65. PubMed ID: 21664898
    [Abstract] [Full Text] [Related]

  • 13. [Antifibrotic effects of cyclic RGD-peptide mediated liposomal interferon: an experimental on rats].
    Du SL, Wang JY, Pan H, Lu WY, Wang J.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 20; 85(15):1015-20. PubMed ID: 16029541
    [Abstract] [Full Text] [Related]

  • 14. Tetramethylpyrazine inhibits angiotensin II-induced activation of hepatic stellate cells associated with interference of platelet-derived growth factor β receptor pathways.
    Zhang X, Zhang F, Kong D, Wu X, Lian N, Chen L, Lu Y, Zheng S.
    FEBS J; 2014 Jun 20; 281(12):2754-68. PubMed ID: 24725506
    [Abstract] [Full Text] [Related]

  • 15. Cocktail therapy with a combination of interferon, ribavirin and angiotensin-II type 1 receptor blocker attenuates murine liver fibrosis development.
    Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Aihara Y, Shirai Y, Yoshii J, Yanase K, Fukui H.
    Int J Mol Med; 2011 Jul 20; 28(1):81-8. PubMed ID: 21455560
    [Abstract] [Full Text] [Related]

  • 16. Ribozymes against TGFbeta1 reverse character of activated hepatic stellate cells in vitro and inhibit liver fibrosis in rats.
    Song YH, Chen XL, Kong XJ, Liu NZ, Li W, Wu XL, Lin JS, Jin YX.
    J Gene Med; 2005 Jul 20; 7(7):965-76. PubMed ID: 15772939
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3.
    Shaaban AA, Shaker ME, Zalata KR, El-kashef HA, Ibrahim TM.
    Chem Biol Interact; 2014 Jan 25; 207():81-91. PubMed ID: 24144775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.